Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Control Intervention2: NIL: NIL
Sponsors
Sami Labs Limited
Eligibility
Inclusion criteria
Inclusion criteria: A) APPLICABLE FOR NORMAL SUBJECTS 1 Adult male and female between 18 to 45 years of age. 2 For normal subjects who currently have no signs and symptoms of any viral/bacterial infection; Body temperature between 97º to 99º F and SpO2 > 90%. 3 Literate subject willing to give signed informed consent. B) APPLICABLE FOR COVIDâ??19 SUBJECTS 1 Adult male and female between 18 to 45 years of age. 2 Confirmed COVID-19 (SARS-CoV-2 ) infection by nasopharyngeal swab RT-PCR test on the same day. 3 COVID-19 patients in stable condition with fever, dyspnea without hypoxemia. 4 Literate subject willing to give signed informed consent.
Exclusion criteria
Exclusion criteria: A) APPLICABLE FOR NORMAL SUBJECTS 1 Patients participation in any another study including macro/micro/any other forms of dietary supplements/multivitamins or disease specific oral nutrition supplements. 2 Any other condition which the principal investigator thinks may jeopardize the safety of subjects. B) APPLICABLE FOR COVID -19 PATIENTS 1 Asymptomatic COVID-19 positive patients. 2 On Tube feeding or parenteral nutrition. 3 Admission to isolation ward > 24hrs of confirmed COVID-19 positive test. 4 Patients on ventilator support. 5 Patients whose condition is unstable. 6 Patients participation in any another study including macro/micro/any other forms of dietary supplements/multivitamins or disease specific oral nutrition supplements. 7 Any other condition which the principal investigator thinks may jeopardize the safety of subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 To analyze the selenium levels in blood and urine of symptomatic COVID-19 positive patients and normal adult subjects. 2 To compare the mean selenium levels in blood and urine of COVID-19 positive patients and normal adult subjects.Timepoint: 1 Selenium levels in blood and urine of symptomatic COVID-19 positive and normal adult subjects (Post enrolment). 2 Mean selenium level comparison in blood and urine of COVID-19 positive and normal adult subjects (Post enrolment). | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Kalpesh Shah
ClinWorld Private Limited
Outcome results
None listed